IPI – was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.
Edited by our carefully selected editorial advisory panel, and extensive research network, IPI provides a proven supportive means of communication to the pharmaceutical, bio pharmaceutical, nutraceutical and medical devices industry the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies which will enable them to be more efficient, bring products to market faster, reduce cost and make healthcare accessible to all.
We have established a strong presence in the US, Central Europe, Middle East, Latin America, Eastern Europe, Asia and Africa which are becoming increasingly important to the way the industry is moving forward in areas of Research and Development, Trials, Manufacturing and Technology Transfer.
OINDP news provides up-to-date information of interest to developers and manufacturers of inhaled and nasal drugs. Approximately 3,100 unique visitors per month and over 500 subscribers to the weekly newsletter rely on OINDPnews for industry news, supplier listings, job listings, event listings, and feature articles.
ONdrugDelivery is the topic-specific publication that focuses tightly on one area within the field of drug delivery in each issue. Topics include Novel Oral Delivery Systems, Connecting Drug Delivery, Pulmonary & Nasal, Industrialisation, Skin Drug Delivery: Dermal, Transdermal & Microneedles, and PFS & Injection Devices. Established for 14 years, with a global readership and high quality, insightful contributions from leading experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. We know drug delivery.
Subscribe online today to the print or for free digital access: